Literature DB >> 11522708

Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors.

G A Nichols1, T A Hillier, J R Erbey, J B Brown.   

Abstract

OBJECTIVE: To estimate the prevalence and incidence of congestive heart failure (CHF) in populations with and without type 2 diabetes and to identify risk factors for diabetes-associated CHF. RESEARCH DESIGN AND METHODS: We searched the inpatient and outpatient electronic medical records of 9,591 individuals diagnosed with type 2 diabetes before 1 January 1997 and those of an age- and sex-matched control group without diabetes for a diagnosis of CHF. Among those without a baseline diagnosis of CHF, we searched forward for 30 months for incident cases of CHF. We constructed multiple logistic regression models to identify risk factors for both prevalent and incident CHF.
RESULTS: CHF was prevalent in 11.8% (n = 1,131) of diabetic subjects and 4.5% (n = 435) of control subjects at baseline. We observed incident cases of CHF in 7.7% of diabetic subjects free of CHF at baseline (650 of 8,460) and in 3.4% of control subjects (314 of 9,156). In diabetic subjects, age, diabetes duration, insulin use, ischemic heart disease, and elevated serum creatinine were independent risk factors for both prevalent and incident CHF. Better glycemic control at baseline, and improved glycemic and blood pressure control at follow-up predicted the development of CHF.
CONCLUSIONS: Despite controlling for age, duration of diabetes, presence of ischemic heart disease, and presence of hypertension, insulin use was associated with both prevalent and incident CHF. Why insulin use and better glycemic control both at baseline and follow-up independently predicted CHF deserves further study.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11522708     DOI: 10.2337/diacare.24.9.1614

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  134 in total

1.  [Aerobic and strength training in patients with diabetes mellitus type 2 and heart failure].

Authors:  D Niederseer; J Niebauer
Journal:  Herz       Date:  2012-08       Impact factor: 1.443

Review 2.  Treatment strategies for the prevention of heart failure.

Authors:  Justin L Grodin; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2013-12

Review 3.  Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review.

Authors:  Dean T Eurich; Finlay A McAlister; David F Blackburn; Sumit R Majumdar; Ross T Tsuyuki; Janice Varney; Jeffrey A Johnson
Journal:  BMJ       Date:  2007-08-30

Review 4.  Contemporary narrative review on left atrial strain mechanics in echocardiography: cardiomyopathy, valvular heart disease and beyond.

Authors:  Vardhmaan Jain; Raktim Ghosh; Manasvi Gupta; Yoshihito Saijo; Agam Bansal; Medhat Farwati; Rachel Marcus; Allan Klein; Bo Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

Review 5.  Is diabetic cardiomyopathy a specific entity?

Authors:  Mitja Letonja; Danijel Petrovič
Journal:  World J Cardiol       Date:  2014-01-26

6.  Restoring redox balance enhances contractility in heart trabeculae from type 2 diabetic rats exposed to high glucose.

Authors:  Niraj M Bhatt; Miguel A Aon; Carlo G Tocchetti; Xiaoxu Shen; Swati Dey; Genaro Ramirez-Correa; Brian O'Rourke; Wei Dong Gao; Sonia Cortassa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

7.  Metformin in Diabetic Patients with Heart Failure: Safe and Effective?

Authors:  Ijeoma Ananaba Ekeruo; Amirreza Solhpour; Heinrich Taegtmeyer
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-12-01

8.  The influence of sex on cardiovascular outcomes associated with diabetes among older black and white adults.

Authors:  Varsha G Vimalananda; Mary L Biggs; James L Rosenzweig; Mercedes R Carnethon; James B Meigs; Evan L Thacker; David S Siscovick; Kenneth J Mukamal
Journal:  J Diabetes Complications       Date:  2013-12-26       Impact factor: 2.852

Review 9.  Is heart failure different on the two continents (North America and Europe)?

Authors:  Rachel Hughes-Doichev; Mark E Dunlap
Journal:  Curr Cardiol Rep       Date:  2004-05       Impact factor: 2.931

Review 10.  Diabetes and cardiovascular disease: changing the focus from glycemic control to improving long-term survival.

Authors:  Cecilia C Low Wang; Jane E B Reusch
Journal:  Am J Cardiol       Date:  2012-11-06       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.